mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for CTBP2
Gene summary
Basic gene Info.Gene symbolCTBP2
Gene nameC-terminal binding protein 2
Synonyms-
CytomapUCSC genome browser: 10q26.13
Type of geneprotein-coding
RefGenesNM_001083914.1,
NM_001290214.1,NM_001290215.1,NM_001329.2,NM_022802.2,
DescriptionC-terminal-binding protein 2ribeye
Modification date20141207
dbXrefs MIM : 602619
HGNC : HGNC
HPRD : 04016
ProteinUniProt: P56545
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_CTBP2
BioGPS: 1488
PathwayNCI Pathway Interaction Database: CTBP2
KEGG: CTBP2
REACTOME: CTBP2
Pathway Commons: CTBP2
ContextiHOP: CTBP2
ligand binding site mutation search in PubMed: CTBP2
UCL Cancer Institute: CTBP2
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for CTBP2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
V297H298NKIRC1
H242H242YSTAD1
Y212Y212CSTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for CTBP2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
Y212Y212C-1.2015599
H242H242Y-0.60002224
V297H298N-0.55166891
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for CTBP2 from PDB

Top
Differential gene expression and gene-gene network for CTBP2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of CTBP2 and the right PPI network was created from samples without mutations in the LBS of CTBP2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for CTBP2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0033578Prostatic Neoplasms1Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for CTBP2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of CTBP2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NADNAD ZWITTERION2omeBY212 H242
NADNAD ZWITTERION2omeCY212 H242
NADNAD ZWITTERION2omeFY212 H242
NADNAD ZWITTERION4lcjAY212 H242
NADNAD ZWITTERION4lcjDY212 H242
NADNAD ZWITTERION4lcjEY212 H242
NADNAD ZWITTERION4lcjGY212 H242
NADNAD ZWITTERION2omeAY212 H242 V297
NADNAD ZWITTERION2omeDY212 H242 V297
NADNAD ZWITTERION2omeEY212 H242 V297
NADNAD ZWITTERION2omeGY212 H242 V297
NADNAD ZWITTERION2omeHY212 H242 V297
NADNAD ZWITTERION4lcjBY212 H242 V297
NADNAD ZWITTERION4lcjCY212 H242 V297
NADNAD ZWITTERION4lcjFY212 H242 V297
NADNAD ZWITTERION4lcjHY212 H242 V297


Top
Conservation information for LBS of CTBP2
Multiple alignments for P56545 in multiple species
LBSAA sequence# speciesSpecies
A270AFLVNAARGGL4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
A271FLVNAARGGLV4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
A323CTPHTAWYSEQ4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
C243CVSLHCNLNEH4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
D210SVIFYDPYLQD3Homo sapiens, Mus musculus, Rattus norvegicus
D210SVLFYDPYLQD1Bos taurus
D296RGAALDVHESE4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
G105VIVRIGSGYDN4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
G107VRIGSGYDNVD4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
G187TLGLIGFGRTG4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
G189GLIGFGRTGQA4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
H242DCVSLHCNLNE4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
H321LICTPHTAWYS4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
H83GAMMYHTITLT4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
I104RVIVRIGSGYD4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
I186ETLGLIGFGRT4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
L213FYDPYLQDGIE3Homo sapiens, Mus musculus, Rattus norvegicus
L213FYDPYLQDGTE1Bos taurus
N244VSLHCNLNEHN4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
N246LHCNLNEHNHH4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
N249NLNEHNHHLIN4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
P211VIFYDPYLQDG3Homo sapiens, Mus musculus, Rattus norvegicus
P211VLFYDPYLQDG1Bos taurus
R103LRVIVRIGSGY4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
R190LIGFGRTGQAV4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
R272LVNAARGGLVD4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
S106IVRIGSGYDNV4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
T134AAVEETADSTI2Homo sapiens, Bos taurus
T134AAVEETADSTV2Mus musculus, Rattus norvegicus
T191IGFGRTGQAVA4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
V297GAALDVHESEP4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
W324TPHTAWYSEQA4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
Y209FSVIFYDPYLQ3Homo sapiens, Mus musculus, Rattus norvegicus
Y209FSVLFYDPYLQ1Bos taurus
Y212IFYDPYLQDGI3Homo sapiens, Mus musculus, Rattus norvegicus
Y212LFYDPYLQDGT1Bos taurus
Y82VGAMMYHTITL4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas